Exagen Inc. (XGN)
NASDAQ · Services · Services-medical laboratories
$8.60−$0.1356 (−1.55%) on the dayAs of the close; data may be delayed.
XGN price, last 12 months
Key stats
- Previous close
- $8.74
- Open
- $8.80
- Day range
- $8.58 – $9.00
- 52-week range
- $2.59 – $12.23
- Volume
- 242.5K
- Avg volume (20 days)
- 265.9K
- Market cap
- $211.2M
Performance
1W+2.3%
1M+12.2%
3M+87.9%
6M+208.4%
YTD+41.5%
1Y−20.2%
vs S&P 500, 1Y−37.0 pts
Technicals and fundamentals
About Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
- Sector
- Services
- Industry
- Services-medical laboratories
- Listed on
- NASDAQ
- Market cap
- $211.2M